1 Min Read
May 1 (Reuters) - Aeglea Bio Therapeutics Inc
* Files for mixed shelf of up to $150 million - SEC filing Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.